Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

NIOSHTIC-2 Publications Search

Search Results

Upstream signal transduction of NF-kB activation.

Authors
Chen-F; Demers-LM; Shi-X
Source
Curr Drug Targets Inflamm Allergy 2002 Jan, 1(2):137-149
NIOSHTIC No.
20023479
Abstract
NF-kB is a transcription factor governing the expression of genes involved in the immune response, embryo or cell lineage development, cell apoptosis, cell cycle progression, inflammation, and oncogenesis. During the past few years, considerable attention has been paid to the upstream signaling pathways that lead to the activation of NF-kB. Many of these signaling molecules can serve as potential pharmaceutical targets for the specific inhibition of NF-kB activation leading to interruption of disease processes. How these molecules interact with each other is however, still a debatable issue. Since many of the signal molecules in this pathway relay more than one of the upstream signals to downstream targets, it has been suggested that the transmission of signals involves a network, rather than a linear sequence in the activation of NF-kB. Thus, the detailed elucidation of the upstream signaling molecules involved with NF-kB activation will be important to the development of pharmaceutical inhibitors that specifically inhibit the activation of NF-kB. Such inhibitors would be predicted to have potent anti-inflammatory and/or anti-carcinogenic effects.
Keywords
Genes; Immune-reaction; Cell-function; Oncogenesis; Oncogenicity; Pharmaceuticals; Carcinogenesis
Publication Date
20020101
Document Type
Journal Article
Fiscal Year
2002
NTIS Accession No.
NTIS Price
Issue of Publication
2
ISSN
1568-010X
NIOSH Division
HELD
Priority Area
Research Tools and Approaches: Cancer Research Methods
Source Name
Current Drug Targets Inflammation and Allergy
State
WV
TOP